Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements

被引:0
|
作者
Amadou Tidjane Corera
Jean Costentin
Jean-Jacques Bonnet
机构
[1] UPRESA C.N.R.S. 6036,
[2] IFRMP 23,undefined
[3] U.F.R. de Médecine and Pharmacie,undefined
[4] 22 Boulevard Gambetta,undefined
[5] 76000,undefined
[6] Rouen,undefined
[7] France,undefined
关键词
Dopamine transporter Ions Rat striatum In vitro binding [3H]WIN 35,428 [3H]Mazindol;
D O I
暂无
中图分类号
学科分类号
摘要
Effects of ions on the binding of uptake blockers to the rat dopamine transporter (rDAT) labelled with [3H]WIN 35,428 {2β-carbomethoxy-3β-(4-fluorophenyl)[3H] tropane} and [3H]mazindol were studied at 20°C. [3H]WIN 35,428 binding increased with Na+ concentrations of up to 10–60 mM and decreased at higher concentrations. At pH 7.4, incubation media containing NaCl and/or Na2HPO4/NaH2PO4 were less stimulant than an NaHCO3/NaH2PO4 medium and they shifted maximal binding values to higher ionic concentrations. In an NaHCO3/NaH2PO4-buffered medium, Na+ concentrations >10 mM decreased the binding of 0.2 nM [3H]WIN 35,428, but an increase of the radioligand concentration shifted this decrease to the right. [3H]Mazindol binding was stimulated by Na+ concentrations ≤10 mM and was rather unaffected at higher concentrations. The inhibition of [3H]WIN 35,428 binding produced by 130 mM Na+ was independent of the nature of the anion; in contrast, isothionate and H2PO4–/HCO3– produced a more pronounced inhibition of the [3H]mazindol binding than Cl– and Br–, whereas I– tended to be a stimulant.
引用
收藏
页码:213 / 221
页数:8
相关论文
共 49 条
  • [31] FURTHER-STUDIES ON THE NATURE OF POSTSYNAPTIC DOPAMINE UPTAKE AND METABOLISM IN RAT STRIATUM - SODIUM DEPENDENCY AND INVESTIGATION OF A POSSIBLE ROLE FOR CARRIER-MEDIATED UPTAKE INTO SEROTONIN NEURONS
    SCHOEPP, DD
    AZZARO, AJ
    JOURNAL OF NEUROCHEMISTRY, 1985, 44 (06) : 1747 - 1752
  • [32] Assessment of 11C-PE2I binding to the neuronal dopamine transporter in humans with the high-spatial-resolution PET scanner HRRT
    Leroy, Claire
    Comtat, Claude
    Trebossen, Regine
    Syrota, Andre
    Martinot, Jean-Luc
    Ribeiro, Maria-Joao
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 538 - 546
  • [33] Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [H-3]WIN 35,428 binding
    Xu, C
    Coffey, LL
    Reith, MEA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (01) : 64 - 73
  • [34] COMPARISON OF [H-3] WIN 35,428 BINDING, A MARKER FOR DOPAMINE TRANSPORTER, IN EMBRYONIC MESENCEPHALIC NEURONAL CULTURES WITH STRIATAL MEMBRANES OF ADULT-RATS
    VALCHAR, M
    HANBAUER, I
    JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) : 469 - 476
  • [35] HIGH-AFFINITY [H-3] GBR 12783 BINDING TO A SPECIFIC SITE ASSOCIATED WITH THE NEURONAL DOPAMINE UPTAKE COMPLEX IN THE CENTRAL-NERVOUS-SYSTEM
    BONNET, JJ
    PROTAIS, P
    CHAGRAOUI, A
    COSTENTIN, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) : 211 - 222
  • [36] THERMODYNAMIC ANALYSES OF THE BINDING OF SUBSTRATES AND UPTAKE INHIBITORS ON THE NEURONAL CARRIER OF DOPAMINE LABELED WITH [H-3] GBR-12783 OR [H-3] MAZINDOL
    BONNET, JJ
    BENMANSOUR, S
    COSTENTIN, J
    PARKER, EM
    CUBEDDU, LX
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 253 (03): : 1206 - 1214
  • [37] 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
    A. Antonini
    R. Benti
    R. De Notaris
    S. Tesei
    A. Zecchinelli
    G. Sacilotto
    N. Meucci
    M. Canesi
    C. Mariani
    G. Pezzoli
    P. Gerundini
    Neurological Sciences, 2003, 24 : 149 - 150
  • [38] 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
    Antonini, A
    Benti, R
    De Notaris, R
    Tesei, S
    Zecchinelli, A
    Sacilotto, G
    Meucci, N
    Canesi, M
    Mariani, C
    Pezzoli, G
    Gerundini, P
    NEUROLOGICAL SCIENCES, 2003, 24 (03) : 149 - 150
  • [39] Quinolyl analogues of norlobelane: Novel potent inhibitors of [3H]dihydrotetrabenazine binding and [3H]dopamine uptake at the vesicular monoamine transporter-2
    Ding, Derong
    Nickell, Justin R.
    Dwoskin, Linda P.
    Crooks, Peter A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (13) : 2613 - 2616
  • [40] A COMMON BINDING-SITE FOR TRICYCLIC AND NONTRICYCLIC 5-HYDROXYTRYPTAMINE UPTAKE INHIBITORS AT THE SUBSTRATE RECOGNITION SITE OF THE NEURONAL SODIUM-DEPENDENT 5-HYDROXYTRYPTAMINE TRANSPORTER
    GRAHAM, D
    ESNAUD, H
    HABERT, E
    LANGER, SZ
    BIOCHEMICAL PHARMACOLOGY, 1989, 38 (21) : 3819 - 3826